Business Wire

Total Economic Impact Study Reveals a Return on Investment of 184% for Veracode Application Risk Management Platform Customers

Share

Veracode, a global leader in application risk management, today released a commissioned study conducted by Forrester Consulting on The Total Economic Impact™ (TEI) of Veracode’s Application Risk Management Platform. The study revealed that Veracode delivered a 184 percent return on investment (ROI) to customers over a three-year period, as well as a material Net Present Value and a payback period of less than six months.

Specifically, there were four key drivers of the economic impact:

  1. A 75 percent reduction in risk of software-based attacks
  2. 80 percent developer productivity recapture that can be reallocated to product innovation
  3. 85 percent efficiency gained in application security from increased automation
  4. Most noteworthy, a 20 percent growth in revenues from software security that drove new products, new market entries, speed to market, and security as a differentiator

With software supply chain attacks on the rise, security and DevSecOps leaders need ways to source solutions that demonstrably protect their organizations, while helping them prove the value of application risk management. Forrester conducted the TEI study to examine the potential ROI for enterprises using the Veracode platform. Based on a series of interviews with Veracode customers, Forrester constructed a $2 billion “composite organization,” with 10,000 employees, 800 developers, and a business goal of increasing development velocity in support of revenue growth. The findings below are representative of these aggregated insights.

Reduced Risk of Software-based Attacks

Use of the Veracode platform resulted in a 75 percent decrease in the risk of a software supply chain-based attack which reduced associated breach costs for the study’s composite customer by $1.5 million over three years. The composite analysis also revealed annual financial benefits of about $7.1 million per year over a three-year engagement versus an upfront cost of $2.5 million, inclusive of platform fees, internal and third-party development costs, ongoing administration adoption, training and development. When added together, the average NPV, or the total value of an investment opportunity for Veracode customers over three years, stood at $4.6 million, with a payback period of less than six months.

As one study participant, an Application Security Engineer, noted, “We have managed to eliminate all high and very high vulnerabilities across all of the apps now for two months. We run the reports and scans every day, and for two months we have not seen a single high- or very high-severity vulnerability show up. So, they’re not just fixing them; they’re preventing them by the reuse of known secure functions and modules across the code base.”

Developer Productivity Unlocked

The Forrester TEI analysis revealed that giving developers better visibility into security flaws earlier in the development process helps them rapidly reduce security debt. Use of Veracode’s platform resulted in an 80 percent improvement in developer productivity, totaling 70,000 developer hours and $3.41 million that could be reallocated to product innovation for the composite customer.

“We started scanning about a year ago and have worked through [approximately] 60 percent of the outstanding open-source [software flaws]. That’s 20 years of tech debt we’ve worked through in that time, largely because we were able to have the controls in place for software releases with Veracode,” another study participant, a CISO in the healthcare technology field, stated.

Efficiency Through Automation

Forrester determined that customers experience an 85 percent reduction in the effort and time required to remediate flaws when using Veracode’s tooling to automate manual workflows. The study found the use of automation transformed the process and efficacy of AppSec programs by freeing up almost 25,000 hours—equivalent to nearly three years. The resulting productivity gains saved $1.3 million for the composite customer, as well as enabling Veracode customers to scale their scanning capacity.

As one Head of Global Engineering Tools in the professional services sector commented, “I would say [prior to Veracode] we weren’t able to [triage] efficiently enough. … To do that properly then, you would spend at least 10 hours to evaluate [which scans to triage], and now you can do it by a glance.”

Customers Gain Competitive Advantage

Modern enterprises face the constant challenge of innovating and delivering secure code faster to stay ahead of the competition. The Forrester TEI study found using Veracode to accelerate and shift security earlier in the software development lifecycle enabled the composite customer to bring features and products to market faster, open new markets and revenue streams, and use security as a differentiator. Moreover, organizations increased their revenue by 20 percent, which made an additional $940,000 in profits for the composite customer directly attributable to using Veracode’s solution.

Another study participant, a Director of Risk and Security, affirmed Veracode’s innovation and speed of delivery; “We’re constantly delivering new feature functions every two weeks. Back in the day, a customer might be sitting on a version for three years with no feature function improvement and then go through an upgrade that takes six or eight months to get it, whereas now we’re deploying new features and functions every two weeks.”

Additional key findings of the Forrester TEI study included:

  • Augmented reporting capabilities
  • Higher levels of IT spend dedicated to security
  • Optimized technology costs
  • An improved security culture
  • Improved developer experience and security maturity

“Ensuring organizations are effectively securing their software against cyberattacks, while facing the reality of constrained budgets, has never been more critical.” said Tim Jarrett, Group Vice President of Product Management at Veracode. “The Forrester TEI study reaffirms that Veracode not only provides businesses with top-tier services, but also delivers meaningful returns and business impact to increase agility and innovation. I’m grateful to our customers for sharing their experiences and helping us demonstrate the true value of Veracode’s platform. This is why organizations place their trust in us every day.”

The Forrester TEI study provides a framework to evaluate the potential financial impact of the Veracode platform on organizations. Forrester interviewed four representatives with experience using the Veracode platform. For the purposes of this study, Forrester aggregated the interviewees’ experiences and combined the results into a single, “composite organization” with $2 billion in annual revenue, 10,000 full-time employees, 1,000 managed apps, 800 developers, and a business goal of increasing development velocity in support of strategic revenue growth.

For more information on the Total Economic Impact™ of Veracode, download the complete study and join a LinkedIn Live where the benefits will be discussed.

About Veracode

Veracode is a global leader in Application Risk Management for the AI era. Powered by trillions of lines of code scans and a proprietary AI-assisted remediation engine, the Veracode platform is trusted by organizations worldwide to build and maintain secure software from code creation to cloud deployment. Thousands of the world’s leading development and security teams use Veracode every second of every day to get accurate, actionable visibility of exploitable risk, achieve real-time vulnerability remediation, and reduce their security debt at scale. Veracode is a multi-award-winning company offering capabilities to secure the entire software development life cycle, including Veracode Fix, Static Analysis, Dynamic Analysis, Software Composition Analysis, Container Security, Application Security Posture Management, and Penetration Testing.

Learn more at www.veracode.com, on the Veracode blog, and on LinkedIn and X.

Copyright © 2024 Veracode, Inc. All rights reserved. Veracode is a registered trademark of Veracode, Inc. in the United States and may be registered in certain other jurisdictions. All other product names, brands or logos belong to their respective holders. All other trademarks cited herein are property of their respective owners.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240909662523/en/

Contacts

For more information, please contact:
Katy Gwilliam
kgwilliam@veracode.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Kweichow Moutai’s Brand Culture Activities in Greece Foster Sino-Greek Cultural Cooperation21.12.2024 20:41:00 EET | Press release

On December 9th, the exhibition “Longevity in the Tao of Chrysanthemum: The Artistic World of Qi Baishi,” supported by Kweichow Moutai Group, opened at the Athens University History Museum. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241221429801/en/ Gao Shan(R3), and Petros Tatoulis(R2), took a group photo with other guests at the opening ceremony of the exhibition. (Photo: Business Wire) Featuring the works of Qi Baishi, a renowned Chinese painter, the exhibition highlights the unique charm of traditional Chinese culture for Western audiences, while advancing cultural exchange and mutual understanding between China and Greece. Gao Shan, Chairman of the Labor Union at Kweichow Moutai Distillery (Group) Co., Ltd., remarked on the significance of the event, saying, “Qi Baishi employed distinctive Eastern painting techniques to convey the Chinese perspective of the world. Athens, a city celebrated for its great masters and

Vertex Announces US FDA Approval of ALYFTREK ™ , a Once-Daily Next-in-Class CFTR Modulator for the Treatment of Cystic Fibrosis20.12.2024 22:46:00 EET | Press release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has approved ALYFTREK (vanzacaftor/tezacaftor/deutivacaftor), a once-daily next-in-class triple combination cystic fibrosis transmembrane conductance regulator (CFTR) modulator for the treatment of cystic fibrosis (CF) in people 6 years and older who have at least one F508del mutation or another mutation in the CFTR gene that is responsive to ALYFTREK. See below for Important Safety Information, including a Boxed Warning. “ALYFTREK is our fifth CFTR modulator to secure FDA approval and represents another significant milestone in our journey to serially innovate and to improve the lives of people living with cystic fibrosis,” said Reshma Kewalramani, M.D., Chief Executive Officer and President of Vertex. “Our north star for more than 20 years has been to address the underlying cause of cystic fibrosis, treat more people with this disease, and bring more people to normal le

Vertex Announces U.S. FDA Approval for TRIKAFTA (elexacaftor/tezacaftor/ivacaftor and ivacaftor) to Include Additional Non- F508del TRIKAFTA-Responsive Variants20.12.2024 22:35:00 EET | Press release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the U.S. Food and Drug Administration (FDA) has approved the expanded use of TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) for the treatment of people with cystic fibrosis (CF) ages 2 and older who have at least one F508del mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene or a mutation that is responsive to TRIKAFTA based on clinical and/or in vitro data. In addition, safety information on liver injury and liver failure has been updated from warnings and precautions to a boxed warning. With this approval, 94 additional non-F508delCFTR mutations have been added to the TRIKAFTA label, and approximately 300 additional people with CF in the U.S. are now eligible for a medicine to treat the underlying cause of their disease for the first time. “Since its first approval in 2019, TRIKAFTA has had a transformative impact on tens of thousands of people living with cystic fibrosis,” sai

HSBC Continental Europe Enters Into a Memorandum of Understanding Regarding Potential Sale of HSBC Assurances Vie (France) to Matmut Société d’Assurance Mutuelle20.12.2024 21:32:00 EET | Press release

Regulatory News: HSBC Continental Europe has signed a Memorandum of Understanding (‘MOU‘) regarding the potential sale of its French life insurance business, HSBC Assurances Vie (France), to Matmut Société d’Assurance Mutuelle (‘Matmut’) (the “Potential Transaction”). HSBC Assurances Vie (France) provides a wide range of life insurance solutions and services, with over 20 billion euros of outstanding assets, net income1 of 77 million euros and a Solvency II ratio of 287% in 2023. As part of the Potential Transaction, HSBC Continental Europe and Matmut would enter into a long-term arrangement for HSBC Global Asset Management (France) to continue to partner with HSBC Assurances Vie (France). HSBC Assurances Vie (France) will continue its existing distribution arrangements. The Potential Transaction would provide customers and employees of HSBC Insurance Life (France) with the opportunity to join one of the leading French mutual insurance groups, which is in full development, and forms pa

Aarhus University: New Global Study Sheds Light on the Learning Crisis: Three Years After COVID-1920.12.2024 14:00:00 EET | Press release

TIMSS 2023 has revealed an alarming global learning crisis exacerbated by the COVID-19 pandemic. Compared to the long term trend in progress in mathematics and science achievement has not only stalled but reversed when taking school closures into account, with the most vulnerable students facing the steepest losses. Key Findings Global Achievement Decline: A 0.11 standard deviation drop in student performance reflects the pandemic's lasting impact. Disproportionate Impact: Low performers, girls, and language minorities faced losses up to twice the average (0.22 standard deviations), deepening existing inequities. Regional Variations: Countries with prolonged school closures and limited remote learning resources experienced the steepest declines. Why This Matters School closures disrupted the education of over one billion children worldwide, with disadvantaged students suffering the most. “The widening gender gap in STEM fields is particularly troubling,” said Christian Kjeldsen, incomi

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye